Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Change in Inventory: 2017-2025

Historic Change in Inventory for UroGen Pharma (URGN) over the last 6 years, with Sep 2025 value amounting to $1.2 million.

  • UroGen Pharma's Change in Inventory rose 698.03% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $747,000, marking a year-over-year decrease of 71.18%. This contributed to the annual value of $3.6 million for FY2024, which is 163.65% up from last year.
  • As of Q3 2025, UroGen Pharma's Change in Inventory stood at $1.2 million, which was up 362.55% from -$462,000 recorded in Q2 2025.
  • In the past 5 years, UroGen Pharma's Change in Inventory ranged from a high of $1.6 million in Q4 2024 and a low of -$1.6 million during Q1 2025.
  • For the 3-year period, UroGen Pharma's Change in Inventory averaged around $365,091, with its median value being $199,000 (2024).
  • Per our database at Business Quant, UroGen Pharma's Change in Inventory surged by 1,600.00% in 2023 and then slumped by 332.16% in 2025.
  • Over the past 5 years, UroGen Pharma's Change in Inventory (Quarterly) stood at $1.0 million in 2021, then slumped by 127.64% to -$283,000 in 2022, then skyrocketed by 337.10% to $671,000 in 2023, then skyrocketed by 143.37% to $1.6 million in 2024, then skyrocketed by 698.03% to $1.2 million in 2025.
  • Its Change in Inventory stands at $1.2 million for Q3 2025, versus -$462,000 for Q2 2025 and -$1.6 million for Q1 2025.